Jennifer M. Golas

1.1k total citations
24 papers, 893 citations indexed

About

Jennifer M. Golas is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Jennifer M. Golas has authored 24 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Hematology. Recurrent topics in Jennifer M. Golas's work include Quinazolinone synthesis and applications (12 papers), Synthesis and biological activity (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Jennifer M. Golas is often cited by papers focused on Quinazolinone synthesis and applications (12 papers), Synthesis and biological activity (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Jennifer M. Golas collaborates with scholars based in United States and Canada. Jennifer M. Golas's co-authors include Frank Boschelli, Diane H. Boschelli, Fei Ye, Judy Lucas, Kim Arndt, Philip Frost, James J. Gibbons, Biqi Wu, Ana Carolina Barrios Sosa and Yanong D. Wang and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Jennifer M. Golas

24 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer M. Golas United States 14 405 334 315 215 192 24 893
Anthony D. William Singapore 16 378 0.9× 341 1.0× 183 0.6× 261 1.2× 271 1.4× 25 922
Ines Kaupe Austria 10 594 1.5× 125 0.4× 583 1.9× 411 1.9× 218 1.1× 13 1.2k
Guobao Zhang United States 9 305 0.8× 154 0.5× 197 0.6× 124 0.6× 102 0.5× 15 594
Ramesh Jayaraman Singapore 15 433 1.1× 114 0.3× 253 0.8× 344 1.6× 352 1.8× 18 898
Jörg Trappe Switzerland 14 463 1.1× 153 0.5× 105 0.3× 81 0.4× 180 0.9× 15 831
Juiwanna Kushner United States 22 697 1.7× 389 1.2× 228 0.7× 64 0.3× 140 0.7× 31 1.1k
Elena Casale Italy 15 602 1.5× 256 0.8× 113 0.4× 91 0.4× 253 1.3× 28 965
Vassilios Bavetsias United Kingdom 21 1.0k 2.6× 597 1.8× 132 0.4× 60 0.3× 471 2.5× 54 1.7k
Corynn Kasap United States 6 253 0.6× 61 0.2× 214 0.7× 151 0.7× 115 0.6× 12 490
Qi Chao United States 11 445 1.1× 323 1.0× 464 1.5× 225 1.0× 119 0.6× 15 964

Countries citing papers authored by Jennifer M. Golas

Since Specialization
Citations

This map shows the geographic impact of Jennifer M. Golas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M. Golas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M. Golas more than expected).

Fields of papers citing papers by Jennifer M. Golas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer M. Golas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M. Golas. The network helps show where Jennifer M. Golas may publish in the future.

Co-authorship network of co-authors of Jennifer M. Golas

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M. Golas. A scholar is included among the top collaborators of Jennifer M. Golas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M. Golas. Jennifer M. Golas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 21(12). 3627–3631. 17 indexed citations
2.
Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3411–3416. 14 indexed citations
3.
Zapf, Christoph W., Jonathan D. Bloom, Zhong Li, et al.. (2011). Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model. Bioorganic & Medicinal Chemistry Letters. 21(15). 4602–4607. 24 indexed citations
4.
Zapf, Christoph W., Jonathan D. Bloom, Russell G. Dushin, et al.. (2011). Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity. Bioorganic & Medicinal Chemistry Letters. 21(8). 2278–2282. 18 indexed citations
5.
Boschelli, Frank, Jennifer M. Golas, Lei Chen, et al.. (2010). A cell-based screen for inhibitors of protein folding and degradation. Cell Stress and Chaperones. 15(6). 913–927. 10 indexed citations
6.
Boschelli, Diane H., Daniel Wang, Yan Wang, et al.. (2010). Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(9). 2924–2927. 11 indexed citations
7.
Zhang, Nan, Biqi Wu, Diane H. Boschelli, Jennifer M. Golas, & Frank Boschelli. (2009). 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(17). 5071–5074. 6 indexed citations
8.
Boschelli, Diane H., Biqi Wu, Fei Ye, et al.. (2007). Facile preparation of new 4-phenylamino-3-quinolinecarbonitrile Src kinase inhibitors via 7-fluoro intermediates: Identification of potent 7-amino analogs. Bioorganic & Medicinal Chemistry. 16(1). 405–412. 11 indexed citations
9.
Wu, Biqi, Ana Carolina Barrios Sosa, Diane H. Boschelli, et al.. (2006). 7-(Aryl/heteroaryl-2-ylethynyl)-4-phenylamino-3-quinolinecarbonitriles as new Src kinase inhibitors: Addition of water solubilizing groups. Bioorganic & Medicinal Chemistry Letters. 16(15). 3993–3997. 12 indexed citations
10.
Boschelli, Diane H., Ana Carolina Barrios Sosa, Jennifer M. Golas, & Frank Boschelli. (2006). Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: Identification of SKS-927. Bioorganic & Medicinal Chemistry Letters. 17(5). 1358–1361. 10 indexed citations
11.
Boschelli, Diane H., Biqi Wu, Fei Ye, et al.. (2006). Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles. Journal of Medicinal Chemistry. 49(26). 7868–7876. 29 indexed citations
12.
Boschelli, Diane H., et al.. (2005). Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles. Bioorganic & Medicinal Chemistry Letters. 15(21). 4681–4684. 12 indexed citations
13.
Sosa, Ana Carolina Barrios, Diane H. Boschelli, Biqi Wu, Yan Wang, & Jennifer M. Golas. (2005). Further studies on ethenyl and ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of a subnanomolar Src kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 15(6). 1743–1747. 18 indexed citations
14.
Golas, Jennifer M., Judy Lucas, Jonathan Golas, et al.. (2005). SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models. Cancer Research. 65(12). 5358–5364. 115 indexed citations
15.
Boschelli, Diane H., Biqi Wu, Ana Carolina Barrios Sosa, et al.. (2005). Synthesis and Src Kinase Inhibitory Activity of 2-Phenyl- and 2-Thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles. Journal of Medicinal Chemistry. 48(11). 3891–3902. 37 indexed citations
16.
Boschelli, Diane H., Yanong D. Wang, S.A. Johnson, et al.. (2004). 7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases. Journal of Medicinal Chemistry. 47(7). 1599–1601. 51 indexed citations
17.
Sosa, Ana Carolina Barrios, Diane H. Boschelli, Fei Ye, Jennifer M. Golas, & Frank Boschelli. (2004). Synthesis and inhibition of Src kinase activity by 7-ethenyl and 7-ethynyl-4-anilino-3-quinolinecarbonitriles. Bioorganic & Medicinal Chemistry Letters. 14(9). 2155–2158. 14 indexed citations
18.
Boschelli, Diane H., Fei Ye, Biqi Wu, et al.. (2003). Investigation of the effect of varying the 4-anilino and 7-alkoxy groups of 3-quinolinecarbonitriles on the inhibition of Src kinase activity. Bioorganic & Medicinal Chemistry Letters. 13(21). 3797–3800. 6 indexed citations
19.
Boschelli, Diane H., Dennis Powell, Jennifer M. Golas, & Frank Boschelli. (2003). Inhibition of Src kinase activity by 4-anilino-5,10-dihydro-pyrimido[4,5-b]quinolines. Bioorganic & Medicinal Chemistry Letters. 13(18). 2977–2980. 16 indexed citations
20.
Golas, Jennifer M., Kim Arndt, Judy Lucas, et al.. (2003). SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.. PubMed. 63(2). 375–81. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026